Loading... Please wait... Loading... Please wait...
ESTIMATED
(AS OF MARCH 31)
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 03/30/2024 | Q1 2024 | -$0.08 | $614,563 | 12/30/2023 | Q4 2023 | -$0.07 | $698,591 | 09/29/2023 | Q3 2023 | -$0.05 | $554,654 | 06/29/2023 | Q2 2023 | -$0.07 | $316,530 | 03/30/2023 | Q1 2023 | -$0.11 | $142,820 | 12/29/2022 | Q4 2022 | -$0.07 | $138,898 | 09/29/2022 | Q3 2022 | -$0.03 | $432,122 |
|---|
A. Elevai Labs, Inc. Common Stock has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, July 5th, 2024 based off last year's report dates.
A. The conference call for Elevai Labs, Inc. Common Stock's latest earnings report can be listened to online.
A. The conference call transcript for Elevai Labs, Inc. Common Stock's latest earnings report can be read online.
A. Elevai Labs, Inc. Common Stock (NASDAQ:ELAB) has a recorded annual revenue of $1.71 M.
A. Elevai Labs, Inc. Common Stock (NASDAQ:ELAB) has a recorded net income of $1.71 M. Elevai Labs, Inc. Common Stock has generated $-0.4 earnings per share over the last four quarters.
A. Elevai Labs, Inc. Common Stock (NASDAQ:ELAB) has a price-to-earnings ratio of -2.16 and price/earnings-to-growth ratio is 0.02.
